OverviewChartNewsTraderScreen

BNP Paribas Call 105 6MK 19.12.20.../  DE000PC1LLK9  /

EUWAX
12/11/2024  09:09:25 Chg.-0.090 Bid20:13:40 Ask20:13:40 Underlying Strike price Expiration date Option type
0.850EUR -9.57% 0.780
Bid Size: 64,000		 0.790
Ask Size: 64,000		 MERCK CO. D... 105.00 - 19/12/2025 Call
TeleTrader 31/10 Merck's Q3 sales up 4% to $16.7 billion
GlobeNewswire 31/07 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
TeleTrader 30/07 Merck falls 7% after Q2 earnings report
TeleTrader 30/07 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 17/07 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
GlobeNewswire 09/07 Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination ...
GlobeNewswire 27/06 Verizon elects Caroline A. Litchfield to its Board of Directors
GlobeNewswire 27/06 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 25/06 Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of...
GlobeNewswire 18/06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 05/06 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 03/06 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
TeleTrader 29/05 Merck to buy biotech firm EyeBio for up to $3B
GlobeNewswire 29/05 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 29/05 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 06/05 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 02/05 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 25/04 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 02/04 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 06/03 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 04/03 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 02/02 Merck Group to expand investment in South Korea
TeleTrader 01/02 Merck's Q4 sales up 6% to $14.6B